Can regression of LVH be proposed as a substitute criterion in trials of morbi-mortality in hypertension?;La regression de l'hypertrophie ventriculaire gauche peut-elle etre proposee comme critere de substitution aux essais de morbi-mortalite chez l'hypertendu?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue 11 SUPPL., 2000, Pages 1435-1440

  Gosse, Ph ^a   Herpin, D ^b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PROGNOSIS; RISK FACTOR; CARDIOVASCULAR DISEASE; CLASSIFICATION; PATHOLOGY; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; ECHOCARDIOGRAPHY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MORBIDITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0033634716     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials
2. Evaluation clinique : Du critere intermediare au critere de substitution
3. Echocardiographic determination of left ventricular mass in men : Anatomic validation of the method
4. Echocardiographic assessment of left ventricular hypertrophy : Comparison to necropsy findings
5. The committee on M-Mode standardization of the American society of echocardiography. Recommendations regarding quantitation in M-mode echacardiography. Results of a survey of echocardiographic measurements
6. Calculation of left ventricular mass in man
7. Various ways of calculating echocardiographic left ventricular mass and their relative prognosis values
8. Mesure echocardiographique de la masse ventriculaire gauche associant les donnees du mode M et du bidimensionnel
9. Three-dimensional echocardiography : In vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods
10. Value of a simple echocardiographic linear predictor of left ventricular mas in systemic hypertension
11. Standardization of M-mode echocardiographic left ventricular measurements
12. Echocardiographic criteria for left ventricular hypertrophy : The Framingham heart study
13. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
14. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
15. Left ventricular mass and body size in normotensive children and adults : Assessment of allometric relations and of the impact of overweight
16. Which definition for echocardiographic left ventricular hypertrophy?
17. Echocardiographic determinatian of left ventricular hypertrophy in the hypertensive : Which method of indexation af left ventricular mass?
18. Effects of growth on variability of left ventricular mass : Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk
19. The heart in hypertension
20. Varaibilite intra-individuelle et erreurs de mesure : Implications cliniques et epidemiologiques
21. The effects of regression to the mean in serial echographic measurements of left ventricular mass : Quantificatian and clinical implications
22. Regression vers la moyenne et meures echocardiographiques repetees de la masse ventriculaire gauche
23. Reliabiliy of echocardiographic assessment of left ventricular structure and function
24. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patient: The RES trial
25. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension
26. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension
27. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
28. Prognostic implications of echocardiographically, determined left ventricular mass in the Framingham heart study
29. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension
30. Relation of arterial structure and function to left ventricular geometric potterns in hypertensive adults
31. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension
32. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients
33. Regression of left ventricular hypertrophy. A meta-analysis
34. Reversal of left ventricular hypertrophy in essential hypertension : A meta-analysis of randomized double-blind studies.An update including studies until the end of december 1996
35. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5mg versus enalapril 20mg : The LIVE study
36. Determinants of left ventricular function before and after regression of myocardial hypertrophy in hypertension
37. Reduction of left ventricular mass by antihypertensive treatment does not improve exercise performance in essential hypertension
38. Prognostic significance of serial changes in left ventricular mass in essential hypertension
39. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
40. Persistence of left ventricular hypertrophy, is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance : 10 Years of follow-up
41. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy : Multicenter trial
42. Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohart af hypertensive patients